Fluorine in PDB 8cjo: Crystal Structure of Human Tryptophan Hydroxylase 1 in Complex with Inhibitor Km-06-004

Enzymatic activity of Crystal Structure of Human Tryptophan Hydroxylase 1 in Complex with Inhibitor Km-06-004

All present enzymatic activity of Crystal Structure of Human Tryptophan Hydroxylase 1 in Complex with Inhibitor Km-06-004:
1.14.16.4;

Protein crystallography data

The structure of Crystal Structure of Human Tryptophan Hydroxylase 1 in Complex with Inhibitor Km-06-004, PDB code: 8cjo was solved by A.Schuetz, K.Mallow, M.Nazare, E.Specker, U.Heinemann, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 44.31 / 1.87
Space group P 1 21 1
Cell size a, b, c (Å), α, β, γ (°) 47.218, 57.776, 69.6, 90, 109.35, 90
R / Rfree (%) 16.9 / 20.9

Other elements in 8cjo:

The structure of Crystal Structure of Human Tryptophan Hydroxylase 1 in Complex with Inhibitor Km-06-004 also contains other interesting chemical elements:

Chlorine (Cl) 1 atom
Iron (Fe) 1 atom

Fluorine Binding Sites:

The binding sites of Fluorine atom in the Crystal Structure of Human Tryptophan Hydroxylase 1 in Complex with Inhibitor Km-06-004 (pdb code 8cjo). This binding sites where shown within 5.0 Angstroms radius around Fluorine atom.
In total only one binding site of Fluorine was determined in the Crystal Structure of Human Tryptophan Hydroxylase 1 in Complex with Inhibitor Km-06-004, PDB code: 8cjo:

Fluorine binding site 1 out of 1 in 8cjo

Go back to Fluorine Binding Sites List in 8cjo
Fluorine binding site 1 out of 1 in the Crystal Structure of Human Tryptophan Hydroxylase 1 in Complex with Inhibitor Km-06-004


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 1 of Crystal Structure of Human Tryptophan Hydroxylase 1 in Complex with Inhibitor Km-06-004 within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F502

b:31.5
occ:1.00
FAD A:UWL502 0.0 31.5 1.0
CAY A:UWL502 1.4 31.4 1.0
CAJ A:UWL502 2.4 29.7 1.0
CBD A:UWL502 2.4 32.6 1.0
CBF A:UWL502 2.9 26.7 1.0
CBE A:UWL502 3.0 25.8 1.0
CAQ A:UWL502 3.0 26.1 1.0
NBG A:UWL502 3.1 29.5 1.0
CBB A:UWL502 3.4 25.6 1.0
CAK A:UWL502 3.6 30.6 1.0
CBA A:UWL502 3.6 29.9 1.0
CAX A:UWL502 3.6 37.8 1.0
NBH A:UWL502 3.6 25.1 1.0
CAI A:UWL502 3.6 38.7 1.0
CAO A:UWL502 3.7 22.8 1.0
NAS A:UWL502 3.8 27.9 1.0
CD1 A:PHE313 4.0 23.7 1.0
CAZ A:UWL502 4.1 27.1 1.0
CAG A:UWL502 4.1 34.8 1.0
O A:HOH676 4.2 32.5 1.0
CAV A:UWL502 4.2 31.6 1.0
NAT A:UWL502 4.2 26.0 1.0
CAR A:UWL502 4.3 32.1 1.0
CE1 A:PHE313 4.3 26.0 1.0
CBC A:UWL502 4.3 28.4 1.0
CG A:GLU317 4.4 18.8 1.0
CE1 A:TYR312 4.5 22.1 1.0
OAU A:UWL502 4.5 29.8 1.0
OE2 A:GLU317 4.5 20.3 1.0
CAW A:UWL502 4.5 28.5 1.0
CD A:GLU317 4.6 22.8 1.0
OAC A:UWL502 4.7 28.4 1.0
CAH A:UWL502 4.8 28.5 1.0
CAF A:UWL502 5.0 29.2 1.0
CAA A:UWL502 5.0 22.3 1.0
CAP A:UWL502 5.0 25.5 1.0

Reference:

E.Specker, R.Wesolowski, A.Schutz, S.Matthes, K.Mallow, M.Wasinska-Kalwa, L.Winkler, A.Oder, N.Alenina, D.Pleimes, J.P.Von Kries, U.Heinemann, M.Bader, M.Nazare. Structure-Based Design of Xanthine-Imidazopyridines and -Imidazothiazoles As Highly Potent and in Vivo Efficacious Tryptophan Hydroxylase Inhibitors. J.Med.Chem. V. 66 14866 2023.
ISSN: ISSN 0022-2623
PubMed: 37905925
DOI: 10.1021/ACS.JMEDCHEM.3C01454
Page generated: Fri Aug 2 17:13:07 2024

Last articles

Zn in 9JYW
Zn in 9IR4
Zn in 9IR3
Zn in 9GMX
Zn in 9GMW
Zn in 9JEJ
Zn in 9ERF
Zn in 9ERE
Zn in 9EGV
Zn in 9EGW
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy